Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Net Income | 36.64% | -4,814.41% | -82.35% | -246.26% | -3,766.67% |
| Total Depreciation and Amortization | -8.70% | -8.70% | 100.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -470.37% | 667.74% | 22.94% | -442.50% | 350.00% |
| Cash from Operations | -21.45% | -177.73% | -56.01% | -482.24% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -115.46% | -99.60% | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -144.12% | -99.60% | -100.00% | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.54% | -119.83% | -249.24% | -482.24% | -- |